EXECUTIVE ENGAGEMENTS
POOL
1853
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
334
Interactions with Platform & by Email
PARTICIPANTS
74
Unique # Participated
VALIDATIONS
17
Responses Validated*
COMPANIES
10
Responses Validated*
* Login for a full stack data experience
DATE
APR 2021
TABLES
150
PAGES
190
EDITION
5
PRICE
USD 4950
CODE
MCP12875
*Engagement stats are ongoing and dynamic
HIGHLIGHTS & REPORT INDEX
Amid the COVID-19 crisis, the global market for Isothermal Nucleic Acid Amplification Technology (INAAT) estimated at US$2.2 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 10.4% over the analysis period 2020-2027. Infectious Diseases, one of the segments analyzed in the report, is projected to record a 11.1% CAGR and reach US$2.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Blood Screening segment is readjusted to a revised 10.2% CAGR for the next 7-year period.
The Isothermal Nucleic Acid Amplification Technology (INAAT) market in the U.S. is estimated at US$642.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$745.7 Million by the year 2027 trailing a CAGR of 9.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.7% and 8.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.
In the global Research segment, USA, Canada, Japan, China and Europe will drive the 7.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$243 Million in the year 2020 will reach a projected size of US$412.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$501.4 Million by the year 2027.
SELECT PLAYERS
Becton, Dickinson and Company; bioMerieux SA; Eiken Chemical Co., Ltd.; Lucigen Corporation; Meridian Bioscience, Inc.; Nugen Audio; QIAGEN GmbH; Ustar Biotechnologies (Hangzhou) Ltd.
SEGMENTS
» Application (Infectious Diseases, Blood Screening, Research) » End-Use (Hospital, Reference Laboratories, Other End-Uses) » Product (Instruments, Reagents)
GEOGRAPHIES
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Influencer Market Insights |
| World Market Trajectories |
| Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market to Witness Healthy Growth, Driven by Low-cost Advantages |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Rising Incidence of HIV, Hepatitis, and Other Infectious Disease – A Key Factor Propelling the Need for INAAT |
| TABLE: Global Incidence of HIV by Region: 2017 |
| Rising Global Incidence of Cancer Drives the INAAT Market |
| Development of New Technologies to Propel Market Expansion |
| Microfluidic Lab-on-a-chip Technology Aids in Expanding NAAT Use to POCT |
| Global Hepatitis B Incidence and Mortality Rates |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Blood Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Blood Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Active Players in United States |
| USA Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| USA Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| USA Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| USA 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| CANADA |
| Canada Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Canada Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Canada Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Canada 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| JAPAN |
| Active Players in Japan |
| Japan Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Japan Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Japan Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Japan 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| CHINA |
| Active Players in China |
| China Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| China Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| China Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| China 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| EUROPE |
| Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| FRANCE |
| Active Players in France |
| France Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| France Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| France Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| France 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| GERMANY |
| Active Players in Germany |
| Germany Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Germany Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Germany Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Germany 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| ITALY |
| Italy Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Italy Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Italy Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Italy 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| UNITED KINGDOM |
| Active Players in United Kingdom |
| UK Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| UK Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| UK Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| UK 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF EUROPE |
| Rest of Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Rest of Europe Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of Europe Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of Europe 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| ASIA-PACIFIC |
| Asia-Pacific Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Asia-Pacific Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Asia-Pacific Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Asia-Pacific 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| REST OF WORLD |
| Rest of World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Infectious Diseases, Blood Screening and Research Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Application - Percentage Breakdown of Value Sales for Infectious Diseases, Blood Screening and Research for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Instruments and Reagents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by Product - Percentage Breakdown of Value Sales for Instruments and Reagents for the Years 2012, 2020 & 2027 |
| Rest of World Current & Future Analysis for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR |
| Rest of World Historic Review for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Hospital, Reference Laboratories and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR |
| Rest of World 15-Year Perspective for Isothermal Nucleic Acid Amplification Technology (INAAT) by End-Use - Percentage Breakdown of Value Sales for Hospital, Reference Laboratories and Other End-Uses for the Years 2012, 2020 & 2027 |
| IV. COMPETITION |
| Total Companies Profiled: 10 |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com